Chemia Analytics Inc Investors.
Please contact us to receive investor information and updates, or check back here often to see the latest press and news releases pertaining to Chemia Analytics Inc. Chemia is a subsidiary of PerAspera Holdings Ltd.
Would you like to partner with us?
Chemia is already a powerhouse in the industry due in-part to our partnerships with leading Cannabis suppliers, investors, and technology providers. Contact us to learn more.
Keep up to date with recent news and press releases
October 25th, 2019 – Adastra Labs Holdings Ltd. (“Adastra” or the “Company”) announces Chemia Analytics Inc. has been granted an Analytical Testing Licence by Health Canada under the Cannabis Act and Cannabis Regulations. “It’s been a long road, but we’re happy to be here,” said Andy Hale CEO of Adastra Labs Holdings Ltd. Last year on October 18th, Chemia
PerAspera Holdings Ltd. announces submission of licence applications to Health Canada for Adastra Labs and Chemia Analytics.
October 18th, 2018 – PerAspera Holdings Ltd. (“PerAspera” or the “Company”) announces submission of licence applications to Health Canada for Adastra Labs and Chemia Analytics. “I am very proud of the team for being among the first in Canada,if not the first, to submit Standard Processing and Analytical Testing licence applications on the new CTLS
August 25th, 2018 – PerAspera Holdings Ltd. (“PerAspera” or the “Company”) announces the formation of Chemia Analytics Inc. for cannabis testing. Managing Director Andy Hale stated, “With the formation of Chemia Analytics, PerAspera will have an independent cannabis testing business unit that can provide 3rd party services to Adastra Labs while servicing the growing cannabis industry